Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
Burger M, van der Aa MN, van Oers JM, Brinkmann A, van der Kwast TH, Steyerberg EC, Stoehr R, Kirkels WJ, Denzinger S, Wild PJ, Wieland WF, Hofstaedter F, Hartmann A, Zwarthoff EC. Burger M, et al. Among authors: hofstaedter f. Eur Urol. 2008 Oct;54(4):835-43. doi: 10.1016/j.eururo.2007.12.026. Epub 2007 Dec 26. Eur Urol. 2008. PMID: 18166262
High frequency of FGFR3 mutations in adenoid seborrheic keratoses.
Hafner C, van Oers JM, Hartmann A, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Vogt T. Hafner C, et al. Among authors: hofstaedter f. J Invest Dermatol. 2006 Nov;126(11):2404-7. doi: 10.1038/sj.jid.5700422. Epub 2006 Jun 15. J Invest Dermatol. 2006. PMID: 16778799 Free article.
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C, van Oers JM, Vogt T, Landthaler M, Stoehr R, Blaszyk H, Hofstaedter F, Zwarthoff EC, Hartmann A. Hafner C, et al. Among authors: hofstaedter f. J Clin Invest. 2006 Aug;116(8):2201-2207. doi: 10.1172/JCI28163. J Clin Invest. 2006. PMID: 16841094 Free PMC article.
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.
Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A. Stoehr R, et al. Among authors: hofstaedter f. Lab Invest. 2004 Apr;84(4):465-78. doi: 10.1038/labinvest.3700068. Lab Invest. 2004. PMID: 14968126 Free article.
132 results